{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:21:11Z","timestamp":1792614071175,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI136579"],"award-info":[{"award-number":["K23AI136579"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI136579"],"award-info":[{"award-number":["K23AI136579"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24AI141036"],"award-info":[{"award-number":["K24AI141036"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI136579"],"award-info":[{"award-number":["K23AI136579"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA190153"],"award-info":[{"award-number":["U54CA190153"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA190153"],"award-info":[{"award-number":["U54CA190153"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA190153"],"award-info":[{"award-number":["U54CA190153"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA190153"],"award-info":[{"award-number":["U54CA190153"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA254571"],"award-info":[{"award-number":["U54CA254571"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA190153"],"award-info":[{"award-number":["U54CA190153"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kaposi sarcoma is one of the most prevalent HIV-associated malignancies in sub-Saharan Africa and is often diagnosed at advanced stage of disease. Only 50% of KS patients who qualify for chemotherapy receive it and adherence is sub-optimal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>57 patients &gt;\u200918\u00a0years with newly diagnosed KS within the AMPATH clinic network in Western Kenya were purposively selected to participate in semi-structured interviews stratified by whether they had completed, partially completed, or not completed chemotherapy for advanced stage KS. We based the interview guide and coding framework on the situated Information, Motivation, Behavioral Skills (sIMB)\u00a0framework, in which the core patient centered IMB constructs are situated into the socioecological context of receiving care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 57 participants, the median age was 37 (IQR 32\u201341) and the majority were male (68%). Notable barriers to chemotherapy initiation and adherence included lack of financial means, difficulty with convenience of appointments such as distance to facility, appointment times, long lines, limited appointments, intrapersonal barriers such as fear or hopelessness, and lack of proper or sufficient information about chemotherapy. Factors that facilitated chemotherapy initiation and adherence included health literacy, motivation to treat symptoms, improvement on chemotherapy, prioritization of self-care, resilience while experiencing side effects, ability to carry out behavioral skills, obtaining national health insurance, and free chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings about the barriers and facilitators to chemotherapy initiation and adherence for KS in Western Kenya support further work that promotes public health campaigns with reliable cancer and chemotherapy information, improves education about the chemotherapy process and side effects, increases oncology service ability, supports enrollment in national health insurance, and increases incorporation of chronic disease care into existing HIV treatment networks.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13027-022-00444-0","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:05:30Z","timestamp":1657109130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi\u2019s sarcoma in Kenya: a qualitative study"],"prefix":"10.1186","volume":"17","author":[{"given":"Devon E.","family":"McMahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Chemtai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggrey","family":"Semeere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Byakwaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merridy","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Laker-Oketta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestine","family":"Lagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid V.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson","family":"Kiprono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naftali","family":"Busakhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"issue":"5","key":"444_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"1","key":"444_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12978-021-01316-3","volume":"19","author":"S Burrowes","year":"2022","unstructured":"Burrowes S, Holcombe SJ, Leshargie CT, Hernandez A, Ho A, Galivan M, et al. Perceptions of cervical cancer care among Ethiopian women and their providers: a qualitative study. Reprod Health. 2022;19(1):2.","journal-title":"Reprod Health"},{"issue":"4","key":"444_CR3","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/S1470-2045(12)70472-2","volume":"14","author":"TP Kingham","year":"2013","unstructured":"Kingham TP, Alatise OI, Vanderpuye V, Casper C, Abantanga FA, Kamara TB, et al. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 2013;14(4):e158\u201367.","journal-title":"Lancet Oncol"},{"issue":"5","key":"444_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/CCO.0b013e328355e14b","volume":"24","author":"AS Semeere","year":"2012","unstructured":"Semeere AS, Busakhala N, Martin JN. Impact of antiretroviral therapy on the incidence of Kaposi\u2019s sarcoma in resource-rich and resource-limited settings. Curr Opin Oncol. 2012;24(5):522\u201330.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"444_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","volume":"60","author":"A Mosam","year":"2012","unstructured":"Mosam A, Shaik F, Uldrick TS, Esterhuizen T, Friedland GH, Scadden DT, et al. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr. 2012;60(2):150\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"444_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/CCO.0b013e328349428d","volume":"23","author":"SE Krown","year":"2011","unstructured":"Krown SE. Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities. Curr Opin Oncol. 2011;23(5):463\u20138.","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"444_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/cam4.618","volume":"5","author":"A Semeere","year":"2016","unstructured":"Semeere A, Wenger M, Busakhala N, Buziba N, Bwana M, Muyindike W, et al. A prospective ascertainment of cancer incidence in sub-Saharan Africa: the case of Kaposi sarcoma. Cancer Med. 2016;5(5):914\u201328.","journal-title":"Cancer Med"},{"issue":"1","key":"444_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12885-019-6506-3","volume":"20","author":"E Freeman","year":"2020","unstructured":"Freeman E, Busakhala N, Regan S, Asirwa F, Wenger M, Seth D, et al. Real-world use of chemotherapy for Kaposi\u2019s sarcoma in a large community-based HIV primary care system in Kenya. BMC Cancer. 2020;20(1):71.","journal-title":"BMC Cancer"},{"key":"444_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12885-016-2080-0","volume":"16","author":"E Freeman","year":"2016","unstructured":"Freeman E, Semeere A, Wenger M, Bwana M, Asirwa FC, Busakhala N, et al. Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi\u2019s sarcoma in five countries across sub-Saharan Africa. BMC Cancer. 2016;16:65.","journal-title":"BMC Cancer"},{"key":"444_CR10","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1200\/GO.20.00153","volume":"6","author":"LL Lin","year":"2020","unstructured":"Lin LL, Lakomy DS, Chiao EY, Strother RM, Wirth M, Cesarman E, et al. Clinical trials for treatment and prevention of HIV-associated malignancies in Sub-Saharan Africa: building capacity and overcoming barriers. JCO Glob Oncol. 2020;6:1134\u201346.","journal-title":"JCO Glob Oncol"},{"issue":"5","key":"444_CR11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/QAI.0000000000002699","volume":"87","author":"EE Freeman","year":"2021","unstructured":"Freeman EE, Semeere A, McMahon DE, Byakwaga H, Laker-Oketta M, Regan S, et al. Beyond T staging in the \u201cTreat-All\u201d era: severity and heterogeneity of Kaposi sarcoma in East Africa. J Acquir Immune Defic Syndr. 2021;87(5):1119\u201327.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"444_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1177\/1359105311398727","volume":"16","author":"AK Rivet","year":"2011","unstructured":"Rivet AK. A situated-Information Motivation Behavioral Skills Model of Care Initiation and Maintenance (sIMB-CIM): an IMB model based approach to understanding and intervening in engagement in care for chronic medical conditions. J Health Psychol. 2011;16(7):1071\u201381.","journal-title":"J Health Psychol"},{"issue":"1","key":"444_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12939-019-1116-x","volume":"19","author":"R Mbau","year":"2020","unstructured":"Mbau R, Kabia E, Honda A, Hanson K, Barasa E. Examining purchasing reforms towards universal health coverage by the National Hospital Insurance Fund in Kenya. Int J Equity Health. 2020;19(1):19.","journal-title":"Int J Equity Health"},{"issue":"4","key":"444_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/23288604.2018.1513267","volume":"4","author":"E Barasa","year":"2018","unstructured":"Barasa E, Rogo K, Mwaura N, Chuma J. Kenya National Hospital Insurance Fund Reforms: implications and Lessons for Universal Health Coverage. Health Syst Reform. 2018;4(4):346\u201361.","journal-title":"Health Syst Reform"},{"key":"444_CR15","doi-asserted-by":"crossref","unstructured":"McMahon DE, Semeere A, Laker-Oketta M, Byakwaga H, Mugglin C, Duda SN, et al. Global disparities in skin cancer services at HIV treatment centers across 29 countries. J Invest Dermatol. 2021.","DOI":"10.1016\/j.jid.2021.02.758"},{"issue":"4","key":"444_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamadermatol.2020.5851","volume":"157","author":"DE McMahon","year":"2021","unstructured":"McMahon DE, Laker-Oketta M, Peters GA, McMahon PW, Oyesiku L, Freeman EE. Skin biopsy equipment availability across 7 low-income countries: a cross-sectional study of 6053 health facilities. JAMA Dermatol. 2021;157(4):462\u20134.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"444_CR17","doi-asserted-by":"publisher","first-page":"18588","DOI":"10.7448\/IAS.16.1.18588","volume":"16","author":"A Gourlay","year":"2013","unstructured":"Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013;16(1):18588.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"444_CR18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.5588\/ijtld.10.0741","volume":"15","author":"M Kumwenda","year":"2011","unstructured":"Kumwenda M, Tom S, Chan AK, Mwinjiwa E, Sodhi S, Joshua M, et al. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi. Int J Tuberc Lung Dis. 2011;15(12):1663\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"444_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1200\/GO.20.00079","volume":"7","author":"LM Burt","year":"2021","unstructured":"Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, et al. Cervix cancer in sub-Saharan Africa: an assessment of cervical cancer management. JCO Glob Oncol. 2021;7:173\u201382.","journal-title":"JCO Glob Oncol"},{"issue":"1","key":"444_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13058-019-1174-4","volume":"21","author":"M Foerster","year":"2019","unstructured":"Foerster M, Anderson BO, McKenzie F, Galukande M, Anele A, Adisa C, et al. Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study. Breast Cancer Res. 2019;21(1):93.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"444_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1037\/0278-6133.25.4.462","volume":"25","author":"JD Fisher","year":"2006","unstructured":"Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462\u201373.","journal-title":"Health Psychol"},{"issue":"4","key":"444_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11904-008-0028-y","volume":"5","author":"JD Fisher","year":"2008","unstructured":"Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV\/AIDS Rep. 2008;5(4):193\u2013203.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"444_CR23","doi-asserted-by":"crossref","unstructured":"Pollard R, Kennedy CE, Hutton HE, Mulamba J, Mbabali I, Anok A, et al. HIV prevention and treatment behavior change and the situated information motivation behavioral skills (sIMB) Model: a qualitative evaluation of a community health worker intervention in Rakai, Uganda. AIDS Behav. 2021.","DOI":"10.1007\/s10461-021-03391-w"},{"issue":"6","key":"444_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/09540121.2013.845283","volume":"26","author":"DJ Konkle-Parker","year":"2014","unstructured":"Konkle-Parker DJ, Amico KR, McKinney VE. Effects of an intervention addressing information, motivation, and behavioral skills on HIV care adherence in a southern clinic cohort. AIDS Care. 2014;26(6):674\u201383.","journal-title":"AIDS Care"},{"key":"444_CR25","doi-asserted-by":"crossref","unstructured":"Mannheimer SB, Morse E, Matts JP, Andrews L, Child C, Schmetter B, et al. Sustained benefit from a long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S41\u20137.","DOI":"10.1097\/01.qai.0000245887.58886.ac"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-022-00444-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:05:35Z","timestamp":1657109135000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-022-00444-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1186\/s13027-022-00444-0","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"3 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Moi University Institutional Research Ethics Committee (IREC) and Partners Healthcare Institutional Review Board (IRB); all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}